Benson MC - Search Results

1

Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.

Petrylak DP, Ankerst DP, Jiang CS, Tangen CM, Hussain MH, Lara PN Jr, Jones JA, Taplin ME, Burch PA, Kohli M, Benson MC, Small EJ, Raghavan D, Crawford ED. Petrylak DP, et al. Among authors: benson mc. J Natl Cancer Inst. 2006 Apr 19;98(8):516-21. doi: 10.1093/jnci/djj129. J Natl Cancer Inst. 2006. PMID: 16622120

2

The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen.

Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. Benson MC, et al. J Urol. 1992 Mar;147(3 Pt 2):817-21. doi: 10.1016/s0022-5347(17)37394-9. J Urol. 1992. PMID: 1371555

3

Fine-needle aspiration of the prostate.

Benson MC. Benson MC. NCI Monogr. 1988;(7):19-24. NCI Monogr. 1988. PMID: 3050537 Review.

4

Predictive value of prostate-specific antigen density for the presence of micrometastatic carcinoma of the prostate.

Seaman EK, Whang IS, Cooner W, Olsson CA, Benson MC. Seaman EK, et al. Among authors: benson mc. Urology. 1994 May;43(5):645-8. doi: 10.1016/0090-4295(94)90179-1. Urology. 1994. PMID: 7513107 Free article.

5

Prostate specific antigen and prostate specific antigen density. Roles in patient evaluation and management.

Benson MC, Olsson CA. Benson MC, et al. Cancer. 1994 Sep 15;74(6):1667-73. doi: 10.1002/1097-0142(19940915)74:6<1667::aid-cncr2820740605>3.0.co;2-2. Cancer. 1994. PMID: 7521783

6

Prostate-specific antigen density: a new prognostic indicator for prostate cancer.

Zentner PG, Pao LK, Benson MC, McMahon DJ, Schiff PB. Zentner PG, et al. Among authors: benson mc. Int J Radiat Oncol Biol Phys. 1993 Sep 1;27(1):47-58. doi: 10.1016/0360-3016(93)90420-z. Int J Radiat Oncol Biol Phys. 1993. PMID: 7690018

7

Transferrin receptor expression in testis cancer.

Petrylak DP, Yagoda A, O'Toole KM, Chadburn A, Sawczuk IS, Benson MC, Olsson CA, Allegretta L, Saad AD, Wartinger DD. Petrylak DP, et al. Among authors: benson mc. J Natl Cancer Inst. 1994 Apr 20;86(8):636-7. doi: 10.1093/jnci/86.8.636-a. J Natl Cancer Inst. 1994. PMID: 8145279 No abstract available.

8

Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy.

Olsson CA, de Vries GM, Raffo AJ, Benson MC, O'Toole K, Cao Y, Buttyan RE, Katz AE. Olsson CA, et al. Among authors: benson mc. J Urol. 1996 May;155(5):1557-62. J Urol. 1996. PMID: 8627821 Free article.

9

Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer.

Katz AE, de Vries GM, Begg MD, Raffo AJ, Cama C, O'Toole K, Buttyan R, Benson MC, Olsson CA. Katz AE, et al. Among authors: benson mc. Cancer. 1995 Apr 1;75(7):1642-8. doi: 10.1002/1097-0142(19950401)75:7<1642::aid-cncr2820750714>3.0.co;2-1. Cancer. 1995. PMID: 8826922

10

Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay in patients with early stage prostate carcinoma. Independence from other pretreatment characteristics.

Ennis RD, Katz AE, de Vries GM, Heitjan DF, O'Toole KM, Rubin M, Buttyan R, Benson MC, Schiff PB. Ennis RD, et al. Among authors: benson mc. Cancer. 1997 Jun 15;79(12):2402-8. doi: 10.1002/(sici)1097-0142(19970615)79:12<2402::aid-cncr16>3.0.co;2-v. Cancer. 1997. PMID: 9191530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters